Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
17101 | 617 | 35.5 | 58% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
176 | 3 | DIABETES CARE//ENDOCRINOLOGY & METABOLISM//TYPE 2 DIABETES | 58057 |
1167 | 2 | GLUCAGON LIKE PEPTIDE 1//GLP 1//INCRETIN | 9383 |
17101 | 1 | GLUCAGON RECEPTOR//GLUCAGON RECEPTOR ANTAGONIST//GLUCAGON ANTAGONIST | 617 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GLUCAGON RECEPTOR | authKW | 1123437 | 6% | 58% | 39 |
2 | GLUCAGON RECEPTOR ANTAGONIST | authKW | 839398 | 3% | 81% | 21 |
3 | GLUCAGON ANTAGONIST | authKW | 570572 | 2% | 82% | 14 |
4 | GLUCAGON RECEPTOR GENE | authKW | 380678 | 2% | 77% | 10 |
5 | GLUCAGON | authKW | 216986 | 15% | 5% | 93 |
6 | METAB DISORDERS MOL ENDOCRINOL | address | 111348 | 0% | 75% | 3 |
7 | GLUCAGON ANALOGS | authKW | 98978 | 0% | 100% | 2 |
8 | MESSENGER RNA POLYMORPHISM | authKW | 98978 | 0% | 100% | 2 |
9 | METAB DISORDER MOL ENDOCRINOL | address | 98978 | 0% | 100% | 2 |
10 | UNITE CHIM BIOL NUTR | address | 98978 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 4457 | 33% | 0% | 204 |
2 | Biochemistry & Molecular Biology | 706 | 31% | 0% | 189 |
3 | Chemistry, Medicinal | 322 | 7% | 0% | 46 |
4 | Biophysics | 226 | 8% | 0% | 49 |
5 | Medicine, Research & Experimental | 208 | 8% | 0% | 49 |
6 | Cell Biology | 102 | 9% | 0% | 53 |
7 | Pharmacology & Pharmacy | 80 | 9% | 0% | 57 |
8 | Physiology | 65 | 5% | 0% | 28 |
9 | Gastroenterology & Hepatology | 29 | 3% | 0% | 18 |
10 | Chemistry, Organic | 13 | 4% | 0% | 24 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | METAB DISORDERS MOL ENDOCRINOL | 111348 | 0% | 75% | 3 |
2 | METAB DISORDER MOL ENDOCRINOL | 98978 | 0% | 100% | 2 |
3 | UNITE CHIM BIOL NUTR | 98978 | 0% | 100% | 2 |
4 | ST S AD TAT RECOGNIT | 55671 | 0% | 38% | 3 |
5 | 149 RUE DE SEV | 49489 | 0% | 100% | 1 |
6 | ANIM OURCESD | 49489 | 0% | 100% | 1 |
7 | CARDIOMETAB MOL MED | 49489 | 0% | 100% | 1 |
8 | CATTEDRA MALATTIE RICAMBIO VIA GIUSTINIANI 2 | 49489 | 0% | 100% | 1 |
9 | CELL BASED HTS | 49489 | 0% | 100% | 1 |
10 | CHU SAR TILMAN | 49489 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DIABETOLOGIA | 3408 | 4% | 0% | 24 |
2 | DIABETES | 3202 | 5% | 0% | 28 |
3 | DIABETES OBESITY & METABOLISM | 2232 | 2% | 0% | 10 |
4 | BIOMEDICAL RESEARCH-TOKYO | 2146 | 2% | 0% | 11 |
5 | HORMONE AND METABOLIC RESEARCH | 1515 | 2% | 0% | 14 |
6 | MOLECULAR METABOLISM | 1332 | 0% | 1% | 3 |
7 | ENDOCRINOLOGIA JAPONICA | 1256 | 1% | 0% | 6 |
8 | AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 904 | 2% | 0% | 11 |
9 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 835 | 3% | 0% | 21 |
10 | INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH | 701 | 1% | 0% | 6 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GLUCAGON RECEPTOR | 1123437 | 6% | 58% | 39 | Search GLUCAGON+RECEPTOR | Search GLUCAGON+RECEPTOR |
2 | GLUCAGON RECEPTOR ANTAGONIST | 839398 | 3% | 81% | 21 | Search GLUCAGON+RECEPTOR+ANTAGONIST | Search GLUCAGON+RECEPTOR+ANTAGONIST |
3 | GLUCAGON ANTAGONIST | 570572 | 2% | 82% | 14 | Search GLUCAGON+ANTAGONIST | Search GLUCAGON+ANTAGONIST |
4 | GLUCAGON RECEPTOR GENE | 380678 | 2% | 77% | 10 | Search GLUCAGON+RECEPTOR+GENE | Search GLUCAGON+RECEPTOR+GENE |
5 | GLUCAGON | 216986 | 15% | 5% | 93 | Search GLUCAGON | Search GLUCAGON |
6 | GLUCAGON ANALOGS | 98978 | 0% | 100% | 2 | Search GLUCAGON+ANALOGS | Search GLUCAGON+ANALOGS |
7 | MESSENGER RNA POLYMORPHISM | 98978 | 0% | 100% | 2 | Search MESSENGER+RNA+POLYMORPHISM | Search MESSENGER+RNA+POLYMORPHISM |
8 | GCGR | 65984 | 0% | 67% | 2 | Search GCGR | Search GCGR |
9 | GLUCAGON RECEPTOR GCGR | 65984 | 0% | 67% | 2 | Search GLUCAGON+RECEPTOR+GCGR | Search GLUCAGON+RECEPTOR+GCGR |
10 | ACYLATED PEPTIDE ANALOGUES | 49489 | 0% | 100% | 1 | Search ACYLATED+PEPTIDE+ANALOGUES | Search ACYLATED+PEPTIDE+ANALOGUES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | AUTHIER, F , DESBUQUOIS, B , (2008) GLUCAGON RECEPTORS.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 65. ISSUE 12. P. 1880 -1899 | 71 | 49% | 32 |
2 | XIONG, YS , GUO, J , CANDELORE, MR , LIANG, R , MILLER, C , DALLAS-YANG, Q , JIANG, GQ , MCCANN, PE , QURESHI, SA , TONG, XC , ET AL (2012) DISCOVERY OF A NOVEL GLUCAGON RECEPTOR ANTAGONIST N-[(4-{(1S)-1-[3-(3, 5-DICHLOROPHENYL)-5-(6-METHOXYNAPHTHALEN-2-YL)-1H-PYRAZOL-1-YL]ETHYL}PHENYL)CARBONYL]-BETA-ALANINE (MK-0893) FOR THE TREATMENT OF TYPE II DIABETES.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 55. ISSUE 13. P. 6137 -6148 | 36 | 72% | 31 |
3 | FILIPSKI, KJ , (2015) SMALL MOLECULE GLUCAGON RECEPTOR ANTAGONISTS: A PATENT REVIEW (2011-2014).EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 25. ISSUE 7. P. 819 -830 | 28 | 85% | 3 |
4 | MU, J , QURESHI, SA , BRADY, EJ , MUISE, ES , CANDELORE, MR , JIANG, GQ , LI, ZH , WU, MS , YANG, XD , DALLAS-YANG, Q , ET AL (2012) ANTI-DIABETIC EFFICACY AND IMPACT ON AMINO ACID METABOLISM OF GRA1, A NOVEL SMALL-MOLECULE GLUCAGON RECEPTOR ANTAGONIST.PLOS ONE. VOL. 7. ISSUE 11. P. - | 30 | 81% | 21 |
5 | KAZDA, CM , DING, Y , KELLY, RP , GARHYAN, P , SHI, CX , LIM, CN , FU, HD , WATSON, DE , LEWIN, AJ , LANDSCHULZ, WH , ET AL (2016) EVALUATION OF EFFICACY AND SAFETY OF THE GLUCAGON RECEPTOR ANTAGONIST LY2409021 IN PATIENTS WITH TYPE 2 DIABETES: 12-AND 24-WEEK PHASE 2 STUDIES.DIABETES CARE. VOL. 39. ISSUE 7. P. 1241 -1249 | 19 | 76% | 8 |
6 | LI, XC , ZHUO, JL , (2013) CURRENT INSIGHTS AND NEW PERSPECTIVES ON THE ROLES OF HYPERGLUCAGONEMIA IN NON-INSULIN-DEPENDENT TYPE 2 DIABETES.CURRENT HYPERTENSION REPORTS. VOL. 15. ISSUE 5. P. 522-530 | 32 | 70% | 3 |
7 | SHEN, DM , LIN, SNA , PARMEE, ER , (2011) A SURVEY OF SMALL MOLECULE GLUCAGON RECEPTOR ANTAGONISTS FROM RECENT PATENTS (2006-2010).EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 21. ISSUE 8. P. 1211 -1240 | 27 | 77% | 10 |
8 | OKAMOTO, H , KIM, J , AGLIONE, J , LEE, J , CAVINO, K , NA, E , RAFIQUE, A , KIM, JH , HARP, J , VALENZUELA, DM , ET AL (2015) GLUCAGON RECEPTOR BLOCKADE WITH A HUMAN ANTIBODY NORMALIZES BLOOD GLUCOSE IN DIABETIC MICE AND MONKEYS.ENDOCRINOLOGY. VOL. 156. ISSUE 8. P. 2781 -2794 | 30 | 60% | 4 |
9 | FRANKLIN, ZJ , O'HARTE, FPM , IRWIN, N , (2014) EFFECTS OF SHORT-TERM CHEMICAL ABLATION OF GLUCAGON SIGNALLING BY PEPTIDE-BASED GLUCAGON RECEPTOR ANTAGONISTS ON INSULIN SECRETION AND GLUCOSE HOMEOSTASIS IN MICE.BIOLOGICAL CHEMISTRY. VOL. 395. ISSUE 4. P. 433-442 | 24 | 77% | 3 |
10 | SAMMONS, MF , LEE, ECY , (2015) RECENT PROGRESS IN THE DEVELOPMENT OF SMALL-MOLECULE GLUCAGON RECEPTOR ANTAGONISTS.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. VOL. 25. ISSUE 19. P. 4057 -4064 | 19 | 83% | 9 |
Classes with closest relation at Level 1 |